Cardiac fibrosis in mice expressing an inducible myocardial-specific Cre driver

DMM Disease Models and Mechanisms

Volumn 6, Issue 6, 2013, Pages 1470-1476

  Lexow, Jonas ^a   Poggioli, Tommaso ^a   Sarathchandra, Padmini ^a   Santini, Maria Paola ^a   Rosenthal, Nadia ^a,b,c  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY EMBL   (Italy)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TAMOXIFEN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; HEART FUNCTION; HEART HYPERTROPHY; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE FIBROSIS; MALE; MORPHOLOGY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENE;

ANIMALS; INTEGRASES; MICE; MYOCARDIUM;

EID: 84888876770     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.010470     Document Type: Article

References (22)

1. Anastassiadis, K., Glaser, S., Kranz, A., Berhardt, K. and Stewart, A. F. (2010). A practical summary of site-specific recombination, conditional mutagenesis, and tamoxifen induction of CreERT2. Methods Enzymol. 477, 109-123.
2. Andersson, K. B., Birkeland, J. A., Finsen, A. V., Louch, W. E., Sjaastad, I., Wang, Y., Chen, J., Molkentin, J. D., Chien, K. R., Sejersted, O. M. et al. (2009). Moderate heart dysfunction in mice with inducible cardiomyocyte-specific excision of the Serca2 gene. J. Mol. Cell. Cardiol. 47, 180-187.
3. Andersson, K. B., Winer, L. H., Mørk, H. K., Molkentin, J. D. and Jaisser, F. (2010). Tamoxifen administration routes and dosage for inducible Cre-mediated gene disruption in mouse hearts. Transgenic Res. 19, 715-725.
4. Bersell, K., Choudhury, S., Mollova, M., Polizzotti, B. D., Ganapathy, B., Walsh, S., Wadugu, B., Arab, S. and Kühn, B. (2013). Moderate and high amounts of tamoxifen in αMHC-MerCreMer mice induce a DNA damage response, leading to heart failure and death. Dis. Model. Mech. 6, 1459-1469.
5. Buerger, A., Rozhitskaya, O., Sherwood, M. C., Dorfman, A. L., Bisping, E., Abel, E. D., Pu, W. T., Izumo, S. and Jay, P. Y. (2006). Dilated cardiomyopathy resulting from high-level myocardial expression of Cre-recombinase. J. Card. Fail. 12, 392-398.
6. Hall, M. E., Smith, G., Hall, J. E. and Stec, D. E. (2011). Systolic dysfunction in cardiac-specific ligand-inducible MerCreMer transgenic mice. Am. J. Physiol. 301, H253-H260.
7. Hougen, K., Aronsen, J. M., Stokke, M. K., Enger, U., Nygard, S., Andersson, K. B., Christensen, G., Sejersted, O. M. and Sjaastad, I. (2010). Cre-loxP DNA recombination is possible with only minimal unspecific transcriptional changes and without cardiomyopathy in Tg(alphaMHC-MerCreMer) mice. Am. J. Physiol. 299, H1671-H1678.
8. Hsieh, P. C., Segers, V. F., Davis, M. E., MacGillivray, C., Gannon, J., Molkentin, J. D., Robbins, J. and Lee, R. T. (2007). Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat. Med. 13, 970-974.
9. Kemp, R., Ireland, H., Clayton, E., Houghton, C., Howard, L. and Winton, D. J. (2004). Elimination of background recombination: somatic induction of Cre by combined transcriptional regulation and hormone binding affinity. Nucleic Acids Res. 32, e92.
10. Kiermayer, C., Conrad, M., Schneider, M., Schmidt, J. and Brielmeier, M. (2007). Optimization of spatiotemporal gene inactivation in mouse heart by oral application of tamoxifen citrate. Genesis 45, 11-16.
11. Liu, Y., Suckale, J., Masjkur, J., Magro, M. G., Steffen, A., Anastassiadis, K. and Solimena, M. (2010). Tamoxifen-independent recombination in the RIP-CreER mouse. PLoS ONE 5, e13533.
12. Loonstra, A., Vooijs, M., Beverloo, H. B., Allak, B. A., van Drunen, E., Kanaar, R., Berns, A. and Jonkers, J. (2001). Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells. Proc. Natl. Acad. Sci. USA 98, 9209-9214.
13. Madisen, L., Zwingman, T. A., Sunkin, S. M., Oh, S. W., Zariwala, H. A., Gu, H., Ng, L. L., Palmiter, R. D., Hawrylycz, M. J., Jones, A. R. et al. (2010). A robust and highthroughput Cre reporting and characterization system for the whole mouse brain. Nat. Neurosci. 13, 133-140.
14. Nakai, A., Yamaguchi, O., Takeda, T., Higuchi, Y., Hikoso, S., Taniike, M., Omiya, S., Mizote, I., Matsumura, Y., Asahi, M. et al. (2007). The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat. Med. 13, 619-624.
15. Nakamura, E., Nguyen, M. T. and Mackem, S. (2006). Kinetics of tamoxifenregulated Cre activity in mice using a cartilage-specific CreER(T) to assay temporal activity windows along the proximodistal limb skeleton. Dev. Dyn. 235, 2603-2612.
16. Semprini, S., Troup, T. J., Kotelevtseva, N., King, K., Davis, J. R., Mullins, L. J., Chapman, K. E., Dunbar, D. R. and Mullins, J. J. (2007). Cryptic loxP sites in mammalian genomes: genome-wide distribution and relevance for the efficiency of BAC/PAC recombineering techniques. Nucleic Acids Res. 35, 1402-1410.
17. Smedley, D., Salimova, E. and Rosenthal, N. (2011). Cre recombinase resources for conditional mouse mutagenesis. Methods 53, 411-416.
18. Sohal, D. S., Nghiem, M., Crackower, M. A., Witt, S. A., Kimball, T. R., Tymitz, K. M., Penninger, J. M. and Molkentin, J. D. (2001). Temporally regulated and tissuespecific gene manipulations in the adult and embryonic heart using a tamoxifeninducible Cre protein. Circ. Res. 89, 20-25.
19. Stokke, M. K., Hougen, K., Sjaastad, I., Louch, W. E., Briston, S. J., Enger, U. H., Andersson, K. B., Christensen, G., Eisner, D. A., Sejersted, O. M. et al. (2010). Reduced SERCA2 abundance decreases the propensity for Ca2+ wave development in ventricular myocytes. Cardiovasc. Res. 86, 63-71.
20. Touvron, M., Escoubet, B., Mericskay, M., Angelini, A., Lamotte, L., Santini, M. P., Rosenthal, N., Daegelen, D., Tuil, D. and Decaux, J. F. (2012). Locally expressed IGF1 propeptide improves mouse heart function in induced dilated cardiomyopathy by blocking myocardial fibrosis and SRF-dependent CTGF induction. Dis. Model. Mech. 5, 481-491.
21. Wang, D., Patel, V. V., Ricciotti, E., Zhou, R., Levin, M. D., Gao, E., Yu, Z., Ferrari, V. A., Lu, M. M., Xu, J. et al. (2009). Cardiomyocyte cyclooxygenase-2 influences cardiac rhythm and function. Proc. Natl. Acad. Sci. USA 106, 7548-7552.
22. Zhang, Y., Riesterer, C., Ayrall, A. M., Sablitzky, F., Littlewood, T. D. and Reth, M. (1996). Inducible site-directed recombination in mouse embryonic stem cells. Nucleic Acids Res. 24, 543-548.